These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 11913710

  • 1. Soluble Fas and soluble Fas L levels in patients with acute pancreatitis.
    Endo S, Inoue Y, Fujino Y, Yamada Y, Sato N, Wakabayashi G, Sakamoto T, Ishikura H, Tanaka T, Inada K, Sato S.
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):179-86. PubMed ID: 11913710
    [Abstract] [Full Text] [Related]

  • 2. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
    Nakae H, Narita K, Endo S.
    J Crit Care; 2001 Jun; 16(2):59-63. PubMed ID: 11481600
    [Abstract] [Full Text] [Related]

  • 3. Soluble Fas and soluble FasL in multiple organ dysfunction syndrome complicating diffuse peritonitis.
    Kitamura M, Endo S, Sato N, Yaegashi Y, Suxzuki Y, Kojika N, Wakabayashi G.
    Res Commun Mol Pathol Pharmacol; 2004 Jun; 115-116():235-42. PubMed ID: 17564320
    [Abstract] [Full Text] [Related]

  • 4. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC, Murray SL, Balakrishnan VS, Guo D, King AJ, Pereira BJ, Jaber BL.
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [Abstract] [Full Text] [Related]

  • 5. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S, Abraham P, Daniel HD, Ramakrishna BS, Sridharan G.
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [Abstract] [Full Text] [Related]

  • 6. Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF.
    Onalan G, Selam B, Baran Y, Cincik M, Onalan R, Gündüz U, Ural AU, Pabuccu R.
    Hum Reprod; 2005 Sep; 20(9):2391-5. PubMed ID: 15932917
    [Abstract] [Full Text] [Related]

  • 7. Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL.
    Jabłońska E, Kiersnowska-Rogowska B, Rogowski F, Parfieńczyk A, Puzewska W, Bukin M.
    Rocz Akad Med Bialymst; 2005 Sep; 50():204-7. PubMed ID: 16358967
    [Abstract] [Full Text] [Related]

  • 8. Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus.
    Song le H, Binh VQ, Duy DN, Bock TC, Kremsner PG, Luty AJ, Mavoungou E.
    J Med Virol; 2004 Jun; 73(2):244-9. PubMed ID: 15122799
    [Abstract] [Full Text] [Related]

  • 9. [Change in serum levels of soluble Fas and soluble FasL in patients with multiple organ dysfunction syndrome].
    Fu Y, Xiao QM, Wang T, Chen XH, Ai YH.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):691-4. PubMed ID: 17092425
    [Abstract] [Full Text] [Related]

  • 10. sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome.
    Doughty L, Clark RS, Kaplan SS, Sasser H, Carcillo J.
    Pediatr Res; 2002 Dec; 52(6):922-7. PubMed ID: 12438671
    [Abstract] [Full Text] [Related]

  • 11. Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors.
    Kondera-Anasz Z, Mielczarek-Palacz A, Sikora J.
    Apoptosis; 2005 Oct; 10(5):1143-9. PubMed ID: 16151647
    [Abstract] [Full Text] [Related]

  • 12. Fas and Fas ligand: Expression and soluble circulating levels in bile duct carcinoma.
    Murakami M, Sasaki T, Miyata H, Yamasaki S, Kuwahara K, Chayama K.
    Oncol Rep; 2004 Jun; 11(6):1183-6. PubMed ID: 15138553
    [Abstract] [Full Text] [Related]

  • 13. Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose.
    Tagami A, Ohnishi H, Hughes RD.
    Hepatogastroenterology; 2003 Jun; 50(51):742-5. PubMed ID: 12828076
    [Abstract] [Full Text] [Related]

  • 14. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease.
    Takabatake N, Nakamura H, Inoue S, Terashita K, Yuki H, Kato S, Yasumura S, Tomoike H.
    Respir Med; 2000 Dec; 94(12):1215-20. PubMed ID: 11192958
    [Abstract] [Full Text] [Related]

  • 15. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E, Puccetti A, Gerli R, Rigo A, Migliorini P, Simeoni S, Beri R, Dolcino M, Martinelli N, Corrocher R, Lunardi C.
    Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
    [Abstract] [Full Text] [Related]

  • 16. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
    Erdoğan B, Uzaslan E, Budak F, Karadağ M, Ediger D, Oral B, Göral G, Ege E, Gözü O.
    Tuberk Toraks; 2005 Mar; 53(2):127-31. PubMed ID: 16100648
    [Abstract] [Full Text] [Related]

  • 17. Soluble Fas (sFas) and soluble Fas ligand (sFas-L) balance in laryngeal carcinoma before and after surgical treatment.
    Pignataro L, Arisi E, Sambataro G, Corsi MM.
    J Surg Oncol; 2003 Jun; 83(2):112-5. PubMed ID: 12772205
    [Abstract] [Full Text] [Related]

  • 18. Significance of soluble TNF receptor-I in acute-type fulminant hepatitis.
    Tokushige K, Yamaguchi N, Ikeda I, Hashimoto E, Yamauchi K, Hayashi N.
    Am J Gastroenterol; 2000 Aug; 95(8):2040-6. PubMed ID: 10950055
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of soluble molecules associated with evasion of immune surveillance: a study in biliary disease.
    Enjoji M, Yamaguchi K, Nakashima M, Ohta S, Kotoh K, Fukushima M, Kuniyoshi M, Tanaka M, Nakamuta M, Watanabe T, Nawata H.
    Liver Int; 2004 Aug; 24(4):330-4. PubMed ID: 15287856
    [Abstract] [Full Text] [Related]

  • 20. Significance of Fas and Fas ligand in tuberculous lymphadenitis.
    Mustafa T, Mogga SJ, Mfinanga SG, Mørkve O, Sviland L.
    Immunology; 2005 Feb; 114(2):255-62. PubMed ID: 15667570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.